Journal Articles

Donald and Barbara Zucker School of Medicine
Academic Works

2014

Mutations in the Gene That Encodes the F-Actin
Binding Protein Anillin Cause FSGS
R. A. Gbadegesin
G. Hall
A. Adeyemo
N. Hanke
I. Tossidou
See next page for additional authors

Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles
Part of the Nephrology Commons
Recommended Citation
Gbadegesin R, Hall G, Adeyemo A, Hanke N, Tossidou I, Burchette J, Wu G, Homstad A, Singhal PC, Winn M, . Mutations in the
Gene That Encodes the F-Actin Binding Protein Anillin Cause FSGS. . 2014 Jan 01; 25(9):Article 2392 [ p.]. Available from:
https://academicworks.medicine.hofstra.edu/articles/2392. Free full text article.

This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic Works. It has been accepted for
inclusion in Journal Articles by an authorized administrator of Donald and Barbara Zucker School of Medicine Academic Works. For more
information, please contact academicworks@hofstra.edu.

Authors

R. A. Gbadegesin, G. Hall, A. Adeyemo, N. Hanke, I. Tossidou, J. Burchette, G. H. Wu, A. Homstad, P. C.
Singhal, M. P. Winn, and +17 additional authors

This article is available at Donald and Barbara Zucker School of Medicine Academic Works:
https://academicworks.medicine.hofstra.edu/articles/2392

6/20/2018

Mutations in the Gene That Encodes the F-Actin Binding Protein Anillin Cause FSGS

J Am Soc Nephrol. 2014 Sep; 25(9): 1991–2002.
Published online 2014 Mar 27. doi: 10.1681/ASN.2013090976

PMCID: PMC4147982
PMID: 24676636

Mutations in the Gene That Encodes the F-Actin Binding Protein Anillin
Cause FSGS
Rasheed A. Gbadegesin, *† Gentzon Hall,†‡ Adebowale Adeyemo,§ Nils Hanke,ǁ¶ Irini Tossidou,ǁ James Burchette,**
Guanghong Wu,†‡ Alison Homstad,*† Matthew A. Sparks,‡ Jose Gomez,‡ Ruiji Jiang,*† Andrea Alonso,*†
Peter Lavin,†‡†† Peter Conlon,‡‡ Ron Korstanje,¶§§ M. Christine Stander,ǁǁ Ghaidan Shamsan,ǁǁ Moumita Barua,¶¶
Robert Spurney,‡ Pravin C. Singhal,*** Jeffrey B. Kopp,††† Hermann Haller,ǁ¶ David Howell,** Martin R. Pollak,¶¶
Andrey S. Shaw,ǁǁ Mario Schiffer,ǁ¶ and Michelle P. Winn†‡
*
Departments of Pediatrics,
‡
Medicine, and
**
Pathology, and
†
Center for Human Genetics, Duke University Medical Center, Durham, North Carolina;
§
Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda,
Maryland;
ǁ
Department of Nephrology, Hannover Medical School, Hannover, Germany;
¶
Mount Desert Island Biological Laboratory, Salisbury Cove, Maine;
††
Trinity Health Kidney Centre, Tallaght Hospital, Trinity College, Dublin, Ireland;
‡‡
Department of Nephrology, Beaumont Hospital, Dublin, Ireland;
§§
The Jackson Laboratory, Bar Harbor, Maine;
ǁǁ
Howard Hughes Medical Institute, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis,
Missouri;
¶¶
Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts;
***
Feinstein Institute for Medical Research, North Shore-LIJ Health System, Manhasset, New York; and
†††
Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda,
Maryland
Corresponding author.
Correspondence: Dr. Rasheed A. Gbadegesin, Department of Pediatrics, Duke University Medical Center, T-Level RM0909 CHC, Box
3959, Durham, NC 27710. Email: rasheed.gbadegesin@duke.edu
Received 2013 Sep 16; Accepted 2014 Jan 7.
Copyright © 2014 by the American Society of Nephrology

Abstract

Go to:

FSGS is characterized by segmental scarring of the glomerulus and is a leading cause of kidney failure.
Identification of genes causing FSGS has improved our understanding of disease mechanisms and points
to defects in the glomerular epithelial cell, the podocyte, as a major factor in disease pathogenesis. Using a
combination of genome-wide linkage studies and whole-exome sequencing in a kindred with familial
FSGS, we identified a missense mutation R431C in anillin (ANLN), an F-actin binding cell cycle gene, as a
cause of FSGS. We screened 250 additional families with FSGS and found another variant, G618C, that
segregates with disease in a second family with FSGS. We demonstrate upregulation of anillin in
podocytes in kidney biopsy specimens from individuals with FSGS and kidney samples from a murine
model of HIV-1–associated nephropathy. Overexpression of R431C mutant ANLN in immortalized human
podocytes results in enhanced podocyte motility. The mutant anillin displays reduced binding to the slit
diaphragm–associated scaffold protein CD2AP. Knockdown of the ANLN gene in zebrafish morphants
caused a loss of glomerular filtration barrier integrity, podocyte foot process effacement, and an edematous
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phenotype. Collectively, these findings suggest that anillin is important in maintaining the integrity of the
podocyte actin cytoskeleton.
FSGS is a clinicopathologic entity that is characterized by nephrotic syndrome (NS), focally sclerotic
1
glomeruli, and effacement of podocyte foot processes and is a common cause of ESRD. The pathogenesis
of FSGS has not been completely elucidated; however, recent advances in molecular genetics have
provided evidence that disruption of podocyte structure and function is central to its pathogenesis. The
highly specialized apparatus of the glomerular filtration barrier (GFB) is composed of the podocyte and slit
diaphragm, the glomerular basement membrane, and specialized fenestrated endothelium. The podocyte
and slit diaphragm play a central role in maintaining the structural and functional integrity of the GFB.
This is evidenced by the number of genetic mutations found in familial FSGS and NS; many of these gene
2 8
products contribute to signaling at the podocyte slit diaphragm or localize to the podocyte cytoskeleton. –
However, the entire repertoire of genes and proteins that are important in maintaining the functional
integrity of the GFB remains unknown. It is estimated that >90% of the genetic causes of hereditary FSGS
9
and NS remain unknown ; thus, the study of large kindreds remains an invaluable tool for unraveling the
complexity of the molecular interactions that are responsible for maintaining the integrity of the podocyte
and GFB.
We identified a pedigree from the United States with autosomal dominant (AD) FSGS. Linkage analysis
was carried out and we obtained suggestive multipoint logarithm of odds (LOD) scores of 1.7, 1.7, and 1.8
on chromosomes 2p, 5p, and 7p respectively. Whole-exome sequencing identified a deleterious
heterozygous mutation R431C in ANLN, the gene encoding the F-actin binding protein anillin. We found
another variant G618C that segregates with disease in a second family with FSGS. Anillin is important in
10 13
cytokinesis and it interacts with key proteins such as CD2AP and mDia2 during cell division. – In
addition, it regulates cell growth by its interaction with the promigratory and prosurvival phosphoinositide
10 13
3 kinase/AKT (protein kinase B) pathway. – Overexpression of the mutant anillin in immortalized
human podocytes causes increased podocyte motility compared with wild-type overexpression. In contrast
with intact anillin, the mutant displays a significantly reduced binding affinity to CD2AP. These findings
reemphasize the importance of podocyte cell integrity, cell survival pathways, and cell migration in the
pathogenesis of FSGS.

Results

Go to:

Clinical Data and Linkage Analyses
Family 6562 is a 26-member kindred from the United States known to date back four generations. There
are nine affected individuals in this family. Both male and female individuals are affected in at least four
generations and there is male-to-male transmission, consistent with an AD inheritance pattern (Figure 1A).
A summary of clinical findings in affected individuals is shown in Table 1. Briefly, the age of onset of
ESRD occurred between 35 and 75 years. Five people received kidney transplants and there was no
recurrence of FSGS in the renal allograft. Figure 1B is a representative sample of kidney histology from
one of the affected individuals. Disease-causing mutations were not found in known FSGS genes in
3 7
affected individuals. – We performed genome-wide linkage analysis in this family and obtained
multipoint LOD scores of 1.7 on chromosomes 2p and 5p, and 1.8 on chromosome 7p (Figure 1C). The
chromosome 2p, 5p, and 7p regions span physical distances of 33.4, 4.0, and 22.1 Mb, respectively.
Whole Exome and Targeted Podocyte Exome Sequencing
The DNA from the proband was subjected to whole exome sequencing using the Illumina TruSeq
platform. On average, the genomic coverage was 52×. After excluding variants with minor allele
frequencies >1%, 1179 novel variants were identified. The following parameters were used to determine
https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC4147982/?report=printable
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the disease-causing mutation: (1) all variants found in our database of 1600 normal control chromosomes
were removed, (2) known variants that were in dbSNP (http://www-ncbi-nlm-nihgov.medproxy.hofstra.edu/projects/SNP/) and the 1000 Genomes Project (http://www.1000genomes.org/)
were removed, (3) all synonymous variants were removed, and (4) all intronic variants were removed,
except splice site variants and variants in promoter regions. DNA from the same individual was sequenced
using a custom exome chip with 2400 genes that are expressed in human podocytes and was compared
with the whole-exome sequencing results. After applying these parameters, there were 146 potential
disease-causing variants from the whole exome data and 62 from the targeted podocyte exome data (with
20 variants common to both approaches). Six variants in the peaks on chromosomes 2p, 5p, and 7p were
identified and confirmed by Sanger sequencing (Table 2). The ANLN gene is in the chromosome 7p peak (
Figure 1C). A nonsynonymous heterozygous change in exon 7 c. 1291C >T R431C in anillin (ANLN) was
identified in all affected individuals (Figure 1D, top and bottom chromatograms show an affected
individual and a control individual, respectively). Of the six variants in the chromosome 2p, 5p, and 7p
peaks, only the ANLN R431C variant segregated with the disease in the family. The variant was not found
in >1600 control chromosomes. This is an ample number of controls for a rare Mendelian disease; a
14
minimum of 350 controls are needed for 95% power to detect 1% polymorphism frequency. The mutated
residue is conserved in evolution to zebrafish (Figure 1E). In silico modeling showed that the variant is
15 16
damaging, with a polyphen score of 0.91. , The list of potentially pathogenic variants with a minor
allele frequency <1% in chromosome 2p, 5p, and 7p loci is shown in Supplemental Table 1. We screened
100 more families from our cohort and did not find any disease-causing variant, other known and novel
ANLN variants found in this cohort are listed in Supplemental Table 2. We screened 150 more families
from another cohort (MRP) and found another variant exon 10 c. 1852 G>T G618C that segregates with
disease in another family. The G618C variant is predicted to be damaging, with a polyphen score of 0.99.
The variant is absent in the 1000 Genomes Project database. The family with the G618C variant has three
affected individuals in two generations. A DNA sample was available from FG-JG1, FG-JG10, FG-JG12,
FG-JG13, and FG-JG14 (Supplemental Figure 1). The pedigree and results of mutation analysis are shown
in Supplemental Figure 1.
Anillin Is Upregulated in Human and Murine FSGS
Real-time RT-PCR was performed on RNA isolated from kidney, brain, heart, lung, liver, and spleen from
three wild-type 129 Sv/Ev mice. ANLN is ubiquitously expressed in all organs, with the highest level of
expression in the heart (Figure 2A). Immunohistochemical staining of normal human kidney biopsy tissue
using rabbit anti-human anillin polyclonal antibody showed that anillin is widely expressed in tubules but
sparsely expressed in a nuclear pattern in the glomerulus, suggesting that anillin is minimally expressed in
normal podocytes (Figure 2B). This is consistent with a previous observation that anillin is not expressed
17
in terminally differentiated cells that have exited the cell cycle. In renal biopsy specimens from humans
with idiopathic FSGS, expression of anillin was significantly upregulated and synaptopodin expression
was downregulated in areas of the glomerulus that stain strongly for anillin (Figure 2C).
To further delineate the cell population that expresses anillin in the glomerulus, we obtained kidney tissue
18
from rtTA/Vpr (HIVAN VPR) mice, a model that is characterized by abnormal podocyte proliferation
and collapsing FSGS. We performed standard double immunostaining for WT1, a key podocyte gene, and
anillin in wild-type and HIVAN VPR mice (Figure 2, D–K). Anillin expression is increased in the
glomerulus of HIVAN mice (Figure 2J) compared with wild-type mice (Figure 2F). Anillin colocalizes
with WT1 using confocal microscopy in the glomerulus of HIVAN mice, suggesting that the cells
expressing anillin are podocytes (Figure 2K).
Overexpression of R431C ANLN Results in Aberrant Binding to CD2AP
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Anillin associates with CD2AP and Cindr (CIN85), the single Drosophila melanogaster ortholog of
19 20
CD2AP. , CD2AP is an important cytoskeletal protein involved in the cellular adhesion and cell
migration through interactions with various actin regulatory proteins such as CAPZ, cortactin, Rac1, and
19 20
ANLN. , In podocytes, CD2AP has an additional important role as an adaptor molecule linking the slit
19 20
diaphragm protein nephrin to the actin cytoskeleton. , Because CD2AP is an established anillin binding
partner, we posit that the R431C mutation may alter the binding of anillin to CD2AP. To evaluate this, we
performed standard immunofluorescence staining on undifferentiated podocyte cell lines and determined
that endogenous CD2AP targeted to anillin at podocyte plasma membrane blebs (Figure 3A). Because
peripheral membrane blebs have been shown to be sites of dynamic actin polymerization/depolymerization
involved in cell motility, this result suggests that the CD2AP/anillin interaction may be an important actin
21
regulatory component underlying the mechanics of podocyte motility. To understand the effect of the
R431C mutation on anillin and CD2AP interaction, we performed standard immunoprecipitation
experiments with CD2AP in the HEK-293 cell line. Overexpression of the ANLNR431C mutant results in
reduced and defective binding with CD2AP compared with the wild type (P<0.002) (Figure 3, B and C).
These results indicate that the identified disease mutation could alter the known functions of CD2AP in
podocytes.
Overexpression of Wild-Type and Mutant ANLN Causes Aberrant Podocyte Migration
Anillin was previously shown to play a vital role in the promigration and prosurvival phosphoinositide 310 12
kinase/AKT pathway. , We explored the role of defective anillin on podocyte migration. First,
immortalized undifferentiated cultured human podocytes were stably transfected with tGFP empty vector,
tGFP-tagged wild-type (ANLNWT), or mutant (ANLNR431C) anillin constructs using the lentivirus gene
delivery system. We demonstrated 95% transfection efficiency by FACS analyses and also by Western
blotting. We performed standard wound healing assays as a surrogate of podocyte motility on both the wild
22
type and mutant overexpression line. The mutant cell line (ANLNR431C) demonstrated increased cell
motility compared with the overexpression ANLNWT (Figure 4). These findings suggest that anillin may
play a significant role in podocyte cell migration.
Anln Knockdown in Zebrafish Causes Disruption of the GFB
As a test for the in vivo relevance of anillin function, we performed morpholino knockdown experiments in
zebrafish. A splice-donor morpholino specific for the anillin zebrafish ortholog and a scrambled control
were injected and the development of edema was monitored for up to 120 hours postfertilization. The fish
were rated as normal (phenotype I) or having mild edema (phenotype II), severe edema (phenotype III), or
very severe edema (phenotype IV). The majority of the anln morpholino-treated fish developed a severe
edematous phenotype (phenotypes III and IV) in contrast with control morpholino-injected fish and wildtype fish from the same clutches with >90% normal phenotypes (phenotype I) (Figure 5A). Anillinknockdown zebrafish and control injected zebrafish were then injected with FITC-labeled 70-kD dextran
to demonstrate that edema was caused by a systemic loss of high molecular mass proteins. Systemic
fluorescence activity in the retinal vessels of the fish was monitored, utilizing an assay system that we
23 24
have used in the past to verify proteinuria development. , We detected a significant loss of 70-kD
dextran especially in the severe phenotypes of anillin-knockdown fish (Figure 5B). To verify these
25
observations in a second model system, we used the Tg (l-fabp:DBP-EGFP) model system. This
transgenic fish produces significant amounts of a circulating vitamin D–binding protein (DBP) fused to
enhanced green fluorescent protein (EGFP) with a molecular mass of approximately 64 kD. The transgene
expression is driven by a fatty acid binding protein promoter that becomes active 72 hours
postfertilization. When we compared accumulation of this endogenously produced marker in control and
anillin morpholino-injected fish, we documented a similar systemic loss of this high molecular mass
protein in severely but also in mildly affected anillin-knockdown fish (Figure 5C). In addition, dot blot
https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC4147982/?report=printable
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analysis of the fish water revealed that the anillin-knockdown fish had increased DBP-EGFP excretion in
water compared with the control morpholino and the wild-type (Figure 5C). Finally, transmission electron
microscopy (TEM) revealed fusion and almost complete effacement of the podocyte foot processes and
disorganization of the GFB in the anillin-knockdown fish compared with the control (Figure 5D). The
structure of the glomerular basement membrane and the fenestration of the endothelium appeared normal
in the control fish. These data indicate a significant loss of high molecular mass proteins from the
circulation in the absence of functional anillin in this in vivo proteinuria model and also demonstrated
disruption of the GFB specifically with a clear podocyte phenotype on TEM.

Discussion

Go to:

Here we report a new cause of hereditary FSGS using a unique strategy for the identification of diseasecausing mutations in an AD FSGS pedigree. Our strategy utilizes genome-wide linkage analysis and dual
sequencing approaches of the whole exome and a custom-designed capture that was targeted toward genes
that are known to be enriched in the podocyte, the glomerular visceral epithelial cell that is believed to be
central to the pathogenesis of FSGS. With rapid advances in molecular genetics and cell biology, this
method will have wide applicability to diseases in which specific cells or pathways are known to be central
to disease evolution.
We discovered a novel mutation R431C in ANLN, the only gene variant that segregated in affected
individuals in the family under study. The gene encodes for anillin, an F-actin binding protein that is
enriched in the cytoskeleton. Anillin is a 124-kD protein with a nuclear domain, an F-actin binding
17 26
domain, a coiled-coil domain, and a pleckstrin homology domain, among others. , It functions as a
scaffold protein that links RhoA and mDia2 (mouse formin 2) with actin and myosin in the cleavage
furrows that is formed during cytokinesis and cellularization; in addition, it binds and bundles F-actin in
10 13 26
vitro. , , The R431C mutation is in the F-actin binding domain of the protein, suggesting that the
change may affect organization of the actin cytoskeleton.
We sequenced the entire ANLN gene in at least 250 families with FSGS and found an additional variant
G618C that segregate with disease in another family with FSGS. The low frequency of pathogenic ANLN
variants may be because anillin is essential for cell division and it participates in pathways that are critical
12 13
during development. , It is, however, possible that some hypomorphic alleles in ANLN may be
susceptibility factors for FSGS. Additional datasets will need to be examined for ANLN mutations to
determine the actual prevalence. At the mRNA level, anillin is ubiquitously expressed in all organs, with
the highest level of expression in the heart.
We showed expression of anillin in tubules from normal human kidney biopsy samples; however, there
was weak expression in the glomerulus and the podocyte. This finding is not surprising because tubules are
actively dividing cells, whereas adult podocytes are thought to be terminally differentiated. This finding is
consistent with the observation of Field and Alberts that anillin is not expressed in cells that have exited
17
the cell cycle. Interestingly, anillin was upregulated in the glomeruli of kidney biopsies from individuals
with idiopathic FSGS. One possible explanation is that aberrant reentry of podocytes into the cell cycle
and pathologic dedifferentiation may be one of the mechanisms by which defective anillin may cause
FSGS. It is interesting to note that a recent study demonstrated the ability of adult podocytes to reversibly
27
enter the cell cycle in HIV-associated FSGS. To determine whether the cells that are expressing anillin in
the human glomerulus are podocytes, we obtained kidney tissue from a murine model of collapsing FSGS
18
(VPR HIVAN mice). Similar to what we observed in human FSGS, we showed upregulation of anillin in
the glomerulus. In addition, anillin colocalized with WT1, suggesting that the cells expressing anillin are
likely to be abnormal podocytes.
To investigate the mechanisms that contribute to the development of FSGS in patients expressing R431C
anillin, we explored the role of CD2AP binding to normal and mutant anillin. The rationale for these
https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC4147982/?report=printable
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experiments was based on the observation that anillin associates with Cindr, the single ortholog of
19 28
CD2AP/CIN85 in D. melanogaster. , CD2AP is also an important signaling molecule in podocytes
linking the slit diaphragm protein nephrin to the actin cytoskeleton and promoting Akt-dependent
20
signaling. In addition, CD2AP binds actin regulating proteins such as CAPZ and cortactin as well as
29
Rac1; CD2AP is therefore an important cellular protein involved in regulating podocyte migration. Mice
lacking CD2AP develop NS, and mutations predicted to ablate CD2AP expression in humans are
2
associated with FSGS. Similar to CD2AP, anilin serves as a scaffolding protein and binds F-actin, active
12
myosin II, septins, and the small GTPase Rho. In this study, we showed that the wild-type anillin also
binds CD2AP and that this binding is impaired by the R431C mutation. This aberrant binding promoted
increased podocyte motility in the mutant cell line. Because abnormal podocyte motility has been
30 31
associated with both loss of GFB integrity and foot process effacement, , these data are consistent with
the notion that anillin plays a key role in regulating actin cytoskeletal dynamics. These actin regulatory
mechanisms are disrupted by the mutant anillin, which, in turn, may promote the development of
19 20 29
FSGS. , ,
To determine if anillin played a role in regulating GFB integrity in vivo, we generated a zebrafish with a
knockdown of the anln gene. The knockdown zebrafish developed proteinuria, food process effacement,
and an edematous phenotype. Although further studies will be necessary to clarify the functional effect of
mutant anillin in vivo, these data are consistent with the notion that anillin plays a key role in regulating
the integrity of the GFB and not necessarily the mechanisms by which the R431C may cause FSGS.
In summary, we used combined linkage analysis, whole exome sequencing and a podocyte targeted exome
sequencing approach to identify a mutation in ANLN as a cause of hereditary FSGS. The mutation
segregates in the family and was absent from >1600 control chromosomes. Immunohistochemistry,
immunofluorescence, and confocal studies in kidney biopsy tissue from individuals with FSGS and
HIVAN mice showed aberrant overexpression of anillin compared with normal kidney. Mutant ANLN
exhibited reduced binding to adaptor protein CD2AP and promoted aberrant podocyte migration. Anln
zebrafish morphants developed edema, foot process effacement, and a loss of GFB integrity similar to
humans with FSGS. Our findings suggest that anillin is important in regulating podocyte actin cytoskeletal
dynamics and implicates anillin mutations in the pathogenesis of FSGS.

Concise Methods
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Case Ascertainment
This study was approved by the institutional review boards of Duke University Medical Center (Durham,
NC) and Brigham and Women’s Hospital (Boston, MA). Informed and written consent and assent from
minors were obtained from all human participants in this study. All animal protocols were approved by the
National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases and
the Mount Desert Island Biologic Laboratory (MDIBL) Animal Care and Use Committee. Inclusion
32
criteria and determination of affection status are as previously reported. We excluded mutations in known
FSGS genes (NPHS1, NPHS2, PLCE1, ACTN4, TRPC6, and INF2) in all of the affected individuals.
Linkage Analyses
A genome-wide linkage scan was performed using the Illumina Infinium II HumanLinkage-24 genotyping
beadchip assay (Illumina, Inc., San Diego, CA). Genotyping was performed on the 12 individuals from the
family comprising six affected individuals and six unaffected individuals. Two-point and multipoint LOD
scores were calculated for all 5000 single nucleotide polymorphism markers. A rare dominant model was
assumed. A conservative “affecteds-only” analysis was performed to ensure that results obtained were not
because of asymptomatic individuals.
https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC4147982/?report=printable
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Whole Exome Sequencing and Podocyte Exome Sequencing
Whole exome sequencing was performed on the proband using standard protocol. We used the Agilent All
Exon 50MB kit and sequenced to 78.3×coverage using one lane of a HiSEquation 2000 sequencer. Reads
33
were aligned to the Human Reference genome (HG 18) using BWA software. Any homozygous variants
with <10×coverage were also Sanger sequenced to eliminate false negative results. Single nucleotide
34
variants were called using SAMtools. The variants were annotated to Ensembl 50_36l using
SequenceVariantAnalyzer and were analyzed using ATAV software
33 35
(http://www.duke.edu/~minhe/atav/). ,
For podocyte exome sequencing, one of the authors (A.S.) designed an exon capture sequence chip
containing 2400 genes that are enriched in the podocyte. The gene list was derived from microarrays of
human and mouse podocyte cell lines and glomeruli from human kidney biopsies. All known FSGS or
CKD genes identified in genome-wide association studies were added to the list. The MetaCore function
of GeneGO (http://GeneGo.com) was used to place all of these genes into pathways.
Sanger Sequencing
Potential disease-causing variants identified by both whole exome and whole podocyte exome chips were
confirmed by Sanger sequencing. Exon primer sequences and cDNA are listed in Supplemental Tables 3
and 4. All sequences were analyzed with Sequencher software (Gene Codes Corp., Ann Arbor, MI).
In Silico Prediction of the Effect of Amino Acid Substitution
The R431C and the G618C variants in the ANLN gene were entered into SIFT and PolyPhen-2 software to
examine the predicted damaging effect of the amino acid substitution to the function of ANLN. PolyPhen-2
calculates a naïve Bayes posterior probability that any mutation is damaging and this is represented with a
15
score ranging from 0 to 1.
mRNA Extraction from Tissues
Experimental studies were conducted within the first three to four passages of the podocyte subculture.
Total RNA was manually extracted from whole kidney, brain, heart, liver, lung, and spleen tissues from
wild-type mice using an RNeasy Mini kit (Qiagen, Valencia, CA). Tissue was stabilized in RNAlater
solution (Ambion Inc., Austin, TX) immediately after mice were euthanized. Subsequently, 0.5 μg of total
RNA was reverse transcribed into cDNA utilizing the RT system (Promega, Madison, WI) with oligo(dT)
primers, according to the manufacturer’s protocol. Relative expression of the target genes was analyzed by
normalizing to the housekeeping gene β-Actin (primer sequences for ANLN and ANLN cDNA are
provided in Supplemental Tables 2 and 3).
Immunohistochemistry Human Kidney Biopsy
Single-label immunohistochemistry was performed on formalin-fixed, paraffin-embedded tissue sections
using mouse monoclonal synaptopodin antibody clone G1D4 at 1:80 dilution (Acris Antibodies, San
Diego, CA) and anillin rabbit polyclonal antibody at 1:100 and 1:200 dilution (Bethyl Laboratories, Inc.,
Montgomery, TX). Detection of the bound antibody was accomplished with the use of a Bond Refine
horseradish peroxidase–labeled detection system (Leica Microsystems). The bound immune complex was
visualized with the on-line application of diaminobenzidine and subsequently counterstained with
hematoxylin. Completed slides were dehydrated with alcohol, cleared with xylene, and coverslipped with a
permanent mounting media. Double-stain immunohistochemistry was manually performed on paraffinembedded tissue sections by preparing antibody cocktails of synaptopodin (1:80 dilution) and anillin
(1:100 dilution). After paraffin removal, clearing, and quenching of endogenous peroxidase activity and
hydration, tissue sections were pretreated for 20 minutes in 99°C Tris/EDTA epitope retrieval solution.
https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC4147982/?report=printable
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Anillin/synaptopodin antibody cocktails were applied to the tissue sections and incubated for 60 minutes.
Detection of the bound antibodies was accomplished by applying Mach 2 Kit 1 or Mach 2 Kit 2 (Biocare
Medical, Concord CA). Comparative color combinations of tissue sections for anillin/synaptopodin
double-stain immunohistochemistry were performed. The labeled antibody complex was detected by
sequential application of chromogenic substrates diaminobenzidine and Fast Red. Tissue sections were
counterstained with hematoxylin and air dried before coverslipping with a permanent mounting medium.
Immunofluorescence and Confocal Microscopy of Kidney Tissues from HIVAN VPR Mice
rtTA/Vpr (VPR HIVAN) mice were obtained by crossing podocin/rtTA mice (constitutively expresses the
rtTA, which is a fusion protein composed of the TetR repressor and the VP16 transactivation domain from
the podocin promoter) with tetop/Vpr mice (TRE-regulated Vpr gene). HIVAN mice were provided
doxycycline in their drinking water for 6 weeks to induce the expression of the podocyte-specific Vpr
gene, whereas wild-type control mice did not receive doxycycline. For immunofluorescence, mice were
perfused with 10 ml of PBS and then 4 ml of 4% paraformaldehyde. Kidneys were removed and soaked in
4% paraformaldehyde overnight and then placed in 30% sucrose/PBS for 4 hours at 4°C. Kidneys were
frozen in optimal cutting temperature medium at −80°C. Kidney sections were made at 8 μm. Excess water
was removed from tissue by soaking in 100% ETOH for 10 minutes, and then tissue was rehydrated with
graded ETOH baths (95%–70% ETOH) and then water and PBS. Antigen retrieval was performed with 10
mM of citrate buffer (pH 6.0) in a pressure cooker for 20 minutes. Tissue was blocked with 5% factor V
BSA/PBS for 1 hour, and sections were incubated with primary antibodies diluted in 5% factor V
BSA/PBS overnight at 4°C. Slides subsequently were washed in PBS and incubated with secondary
fluorochrome-conjugated antibodies for 45 minutes at room temperature. Slides were coverslipped using
Fluoromount-G containing 2 mg/ml 4′,6-diamidino-2-phenylindole (Sigma-Aldrich, St. Louis, MO). The
following primary antibodies were used: goat anti-ANILLIN (1:100 dilution, EB06104; Everest Biotech,
Ramona, CA), and rabbit anti-WT-1 (1:100 dilution, sc-192; Santa Cruz Biotechnology, Santa Cruz, CA).
The following secondary antibodies were used in 1:500 dilutions for 45 minutes at room temperature:
Alexa 594 donkey anti-rabbit IgG (A-21207) and Alexa 488 donkey anti-goat IgG (A-11055) were
purchased from Invitrogen. Immunofluorescence staining was visualized and photographed using a Zeiss
510 Inverted Confocal Microscope (Carl Zeiss, Jena, Germany).
Immunofluorescence of Podocyte Cell Lines
Immortalized human podocytes were cultured on collagen I–coated coverslips (BD Biosciences, San Jose,
CA) and treated as indicated. Cells were then fixed and washed with PBS and blocked with buffer
containing 5% goat serum before incubation with rabbit polyclonal Anillin antibody (Bethyl Laboratories),
and mouse monoclonal CD2AP antibody (Santa Cruz Biotechnology). Cells were washed with PBS and
secondary Alexa Fluor 488 antibody was applied (Invitrogen) at a concentration of 1:1000 for 1 hour at
room temperature. Cells were washed with PBS before addition of 4′,6-diamidino-2-phenylindole stain at a
concentration of 1:10,000 diluted in PBS. Podocyte immunofluorescence imaging was performed using a
Zeiss AxioImager and the MetaMorph Bioimaging Software.
For lentivirus construction and cell transduction with ANLN, standard molecular cloning methods were
used to replace the ubiquitin-EGFP of FUGW with CMV turboGFP (tGFP vector control), CMV turbo36
WT-ANLN (tGFP-ANLNWT), and CMV turboGFP-mutant-ANLN (tGFP-ANLNR431C). Lentivirus was
made by transfecting 6×106 293FT (Invitrogen) cells with 5 µg VSVg, 15 µg ∆8.9, and 20 µg promoterreporter plasmid using Lipofectamine 2000. After 72 hours, supernatant was harvested, filtered at 0.45 µm,
and pelleted by ultracentrifugation at 26,000 rpm for 2 hours at 4°C. After resuspension in HBSS,
lentivirus was stored at −80°C. Conditionally immortalized human podocytes were then transduced with
either tGFP vector control, tGFP-ANLNWT, or tGFP-ANLNR431C lentiviruses for 24 hours in RPMI 1640
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media. Cells were allowed to grow to 95% confluence before harvest and sorting by flow cytometry. tGFPexpressing cells were then plated in growth media and returned to standard growth permissive conditions.
Wound Healing Assays
Conditionally immortalized human podocytes were transduced with either tGFP vector control, tGFPANLNWT, or tGFP-ANLNR431C lentiviruses for 24 hours and cells were allowed to grow to confluence.
Cell monolayers were washed and scratch wounds were applied using a 1000-µl pipet tip. Podocytes were
imaged using an EVOS microscope at time 0 immediately after wound creation. Cells were then returned
to growth restrictive conditions for 24 hours before final imaging of wound healing.
Immunoblotting and Immunoprecipitation
HEK-293T cells were transfected with plasmids expressing flag epitope-tagged human CD2AP DNA and
wild-type anillin or mutant anillin DNA. The cells were then washed carefully with ice-cold PBS on ice.
For lysis, 900 µl RIPA buffer (50 mM TrisHCl, pH 7.5, 200 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1%
Triton, and 0.25% deoxycholate plus protease inhibitors) was added to cells. The lysate was incubated for
15 minutes on ice and centrifuged at 14,000 rpm for 15 minutes at 4°C. Fifty-microliter flag-beads (50%
slurry in Triton buffer; Sigma-Aldrich) were added to the supernatant and rotated overhead at 4°C for 1
hour (up to overnight). After that, the beads were centrifuged at 3000 rpm for 1 minute at 4°C and washed
with RIPA buffer five times. Proteins were eluted by boiling the beads in Laemmli buffer and separated by
SDS-PAGE.
Zebrafish Stocks and Injections
Zebrafish (AB) were grown and mated at 28.5°C, and embryos were kept and handled in standard E3
37
solution as previously described. Morpholinos were injected in fertilized eggs in the one- to four-cell
stage using a Nanoject II injection device (Drummond Scientific, Broomall, PA). The following
morpholinos were designed and ordered from GeneTools (Philomath, OR): control, 5′CCTCTTACCTCAGTTACAATTTATA-3′; and Anillin, 5′-GGCCCCTGAAAACAGTTGTATAGAT-3′.
Morpholino injections were carried out with concentrations ranging from 50 to 100 µM, with an injection
volume of 4.6 nl in injection buffer (100 mM KCl, 0.1% phenol red). Embryos were monitored for the
development of phenotype until 120 hours postfertilization. The phenotype was scored from one to four,
relative to the amount of edema present.
Eye Assays
Two types of eye assays were performed to assess proteinuria. At 50–55 hours after morpholino injection,
remaining chorions were manually removed from all embryos. For one group, cardinal vein injections
23
were performed as described by Hentschel et al. Briefly, 4.6 µl of FITC-labeled 70-kD dextran
(Molecular Probes, Eugene, OR) was injected into the cardiac venous sinus. For this injection, zebrafish
were anesthetized with a 1:20–1:100 dilution of 4 mg/ml Tricaine (MESAB: ethyl-m-aminobenzoate
methanesulfonate, 1% Na2HPO4, pH 7.0; Sigma-Aldrich) and positioned on their backs in a 1% agarose
injection mold. After the injection, fish were returned to egg water, where they quickly regained motility.
A second assay was performed measuring endogenous fluorescence intensity of retinal blood vessels in Tg
25
(l-fabp:DBP-EGFP) zebrafish (gift from J. Xie and B. Anand-Apte, Cleveland, OH) at 96, 120, and 144
hours after morpholino injection. These animal protocols were approved by the MDIBL Animal Care
Committee.
Image Analyses
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For eye assay measurements, zebrafish larvae were transferred into individual wells of a 96-well plate
(Thermo Fisher Scientific, Pittsburgh, PA). Fish were anesthetized with Tricane and sequential images of
live fish were generated using a Zeiss inverted microscope (Axiovert 200) connected to an AxioCam MRm
charge-coupled device camera, and images were taken with fixed exposure times and gain using the Axio
Vision release 4.5 SP1 software package. The maximum fluorescence intensities of images of the pupil of
the fish were measured using the NIH ImageJ application and are reported in relative units of brightness.
Dot Blot Analyses of Fish Water
For dot blot analysis of fish water, 150 µM of Anillin and control morpholinos was injected into
Tg(Fabp:DBP-eGFP) male crossed with wild-type female embryos. Fish were transferred to 48-well plates
individually (one fish per well) with 500 µl of embryo raising medium at 72 hours and kept at 28°C until
168 hours. Fish were graded for phenotype development, removed from the wells, and the fish water was
stored at −20°C. Only fish water from fish with a heartbeat at 168 hours was used for dot blot analysis. For
the dot blot procedure, 100 µl of fish water from four fish was pooled and blotted on a nitrocellulose
membrane. Immunoblotting was performed using anti-GFP (Abcam, Inc.; ab290) 1:2000/anti-rabbit
1:5000 in PBS/5% nonfat dry milk. Total EGFP protein was extracted from an individual fish and was
used as a positive control on the dot blot in % dilutions as indicated in Figure 5C. Epon embedding of
zebrafish embryos was performed following standard procedures, and TEM of the zebrafish pronephros
was performed.
Statistical Analyses
Continuous variables that were normally distributed were expressed as the mean±SD. Differences between
two groups were compared using the t test. Categorical variables were compared by the chi-squared test
and Fisher’s exact test where indicated. A P value <0.05 was considered statistically significant.
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Figure 1.

ANLN mutation in a kindred with familial FSGS. (A) Pedigree of a family with familial FSGS. There are at least nine
affected family members with male-to-male transmission consistent with an AD mode of transmission. DNA is available
from individuals enclosed in red squares and they are genotyped. (B) Representative kidney biopsy histology from an
affected individual in family 6562 showing an area of segmental glomerulosclerosis. (C) Genome-wide linkage scan using
the Illumina Infinium II HumanLinkage-24 genotyping beadchip assay yields suggestive multipoint LOD scores of 1.7 on
chromosomes 2p and 5p and 1.8 on chromosome 7p in family 6562. Chromosome numbers are shown on the x axis and
LOD scores are on the y axis. ANLN is located in the chromosome 7p peak (red arrow). (D) Missense heterozygous
mutation in exon 7 1291 C>T R431C found in the ANLN gene. Top, mutant sequence; bottom, wild-type sequence. (E)
The R431 residue is conserved in evolution to zebrafish (red box).
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Table 1.
Clinical characteristics of affected family members
ID

Sex

Genotyped
(Yes/No)

Age at Onset Proteinuria
(yr)

1
ID
102

Male
Sex
Female

Yes
Genotyped
Yes
(Yes/No)

104

Female

No

Unknown

1005 Female

Yes

1002 Male

Age at

Transplant

ESRD (yr)

30
Yes
Age at Onset Proteinuria
30
Yes
(yr)

Recurrence of
Disease in Graft

35
Age at
40 (yr)
ESRD

Yes
Transplant
Yes

No
Recurrence of
DiseaseNo
in Graft

Unknown

Unknown

Yes

No

69

Yes

75

No

Unknown

Unknown

Unknown

48

Yes

Unknown

1000 Male

No

Unknown

Unknown

49

Yes

Unknown

2001 Female

No

Unknown

Unknown

36

No

Not applicable

9001 Female

Yes

9

Yes

Unknown

No

Not applicable

9004 Male

Yes

20

Yes

Unknown

No

Not applicable
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Table 2.
Novel heterozygous variants in family 6562
Sequencing Approach

Novel Variants

Variants

Variants in the Linkage

ID of Genes with

(n)

after

Region (n)

Variants

Filtering
(n)
Whole exome
Sequencing Approach

1179

146

6

Novel Variants

Variants

Variants in the Linkage

(n)

after

Region (n)

Filtering
(n)

GCKR
a
RASGRP3
ID of Genes with
ADCY
Variants
C7ORF31
a
ANLN
NKD2

Targeted podocyte exome

145

62

2

Variants common to both

34

20

2

assays

a
RASGRP3
a
ANLN
RASGRP3
ANLN

a

Genes common to both whole exome and targeted podocyte exome.
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Figure 2.

Anillin expression in human and murine FSGS. (A) Real-time PCR is used to assess anillin mRNA expression in different
organs. Anillin is ubiquitously expressed in all organs, including the kidney. All values are normalized for expression in
the spleen. (B) Normal kidney biopsy tissue is double stained for synaptopodin with anti-human mouse mAb with brown
DAB chromogen and anillin anti-human rabbit polyclonal antibody with Fast Red stain. Synaptopodin is strongly
expressed in the glomerulus and the podocyte and the expression of anillin is mainly in the tubules. (C) Double staining
for synaptopodin and anillin in a glomerulus with FSGS shows patchy expression of synaptopodin in the glomerulus and
significant upregulation of anillin expression in the glomerulus and the reactive podocyte (black arrow) compared with
normal kidney tissue. (D–G) The middle panel shows double immunostaining for WT1 (red) and anillin (green) in wildtype mice, and DAPI (blue) for nuclear staining. WT1 is expressed in the glomerulus mainly in the nucleus with little or
no anillin expression. (I–K) In the lower panel, kidney tissues from HIVAN VPR mice showed reduced expression of
WT1 (I), upregulation of anillin in the glomerulus (J), and colocalization of anillin with WT1 (white arrows in K). DAB,
diaminobenzidine; DAPI, 4',6-diamidino-2-phenylindole. Original magnification, ×400 in B and C; ×40 in D–K. Scale
bars in B and C represent a distance of 50 microns; scale bars in D–K represent a distance of 20 microns.
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Figure 3.

Overexpression of R431C ANLN resulted in aberrant binding to CD2AP. (A) Endogenous anillin protein staining is
shown in red. Coimmunolabeling for anti-CD2AP is shown in green. Cell nuclei are stained with DAPI (blue). Anillin is
expressed in both the nucleus and cytoplasm of undifferentiated podocyte and colocalizes with CD2AP in plasma
membrane blebs. (B and C) ANLNWT and ANLNR431C are coexpressed with flag-tagged CD2AP. After
immunoprecipitation with anti-flag antibody, coprecipitation is found with CD2AP. There is significant reduction in
binding of the ANLNR431C to CD2AP compared with the ANLNWT. The difference is quantified in C. DAPI, 4',6diamidino-2-phenylindole.
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Figure 4.

Overexpression of mutant ANLN causes aberrant podocyte migration. Immortalized undifferentiated cultured human
podocytes are stably transfected with tGFP empty vector control, tGFP-tagged WT (ANLNWT), or mutant (ANLNR431C)
anillin constructs using the lentivirus gene delivery system. (A and B) Motility of the mutant cell line is significantly
increased compared with the wild-type overexpression cell line, and both cell lines migrate faster than the tGFP empty
vector control cell line.
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Figure 5.

Open in a separate window
Phenotype of anillin knockdown in zebrafish. (A) ANLN knockdown leads to an edema phenotype in zebrafish
(pericardial effusion, arrow; yolk sac, arrowhead). Fertilized eggs are injected with a control or Anillin-specific splicedonor morpholino and phenotypes are scored at 120 hours post fertilization (hpf). Edema development is graded as
follows: I, no phenotype; II, mild phenotype; III, severe; and IV, very severe phenotype. (B) Anillin-knockdown leads to
loss of injected high molecular mass dextran. Zebrafish larvae 48 hpf postinjection of no morpholino (WT), control
morpholino (Ctrl), or Anillin morpholino are anesthetized and injected with a FITC-labeled 70-kD dextran. The amount of
systemic fluorescence is assessed postinjection by measurement of fluorescence intensity in the retinal blood vessel
plexus at baseline and 24 hours later in individual fish. Loss of systemic fluorescence indicates systemic loss of high
molecular mass proteins from the circulation, especially in fish with a severe edema phenotype (PIII/PIV). (C) Anillinhttps://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC4147982/?report=printable
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knockdown leads to loss of systemic fluorescence in Tg (l-fabp:DBP-EGFP) zebrafish. Tg (l-fabp:DBP-EGFP) zebrafish
develop from 96 hpf until 144 hpf, increasing systemic fluorescence by increasing amounts of circulating EGFP-labeled
vitamin D binding protein (molecular mass of approximately 64 kD). Anillin knockdown causes a significant reduction in
systemic fluorescence in mild (phenotype I/II) and severely affected (phenotype III/IV) knockdown fish, indicating again
systemic loss of high molecular mass proteins. A dot blot assay of DBP-EGFP expression in fish water from anillinknockdown zebrafish shows strongly detectable fluorescence compared with both control and wild-type fish. (D) TEM of
the GFB. In the control morpholino-injected embryo, podocyte foot processes and intervening slit diaphragm architecture
are preserved (boxed area in Da and white arrow in Da’). In the anillin-knockdown fish, there is effacement and fusion of
the podocyte foot process with disruption of the slit diaphragm (boxed area in Db and white arrow head in Db’). Bar, 500
nm in D.
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